MedPath

The Effectiveness and Safety of the Trial of Labor in Full Term Pregnant Women With Cesarean Section After Spontaneous Labor

Recruiting
Conditions
Trial of Labor After Cesarean
Spontaneous Labor
Vaginal Birth After Cesarean
Registration Number
NCT05215041
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

This study is a multi-center, prospective, observational clinical trial study. 510 full-term pregnant women will be enrolled as subjects, and the ratio of eligible subjects in the two groups is 1:1. In the cesarean section group, full term pregnant women with one prior cesarean section after spontaneous labor who are willing to try the trial of labor after cesarean (TOLAC) and in accordance with the criteria according to the 2016 China vaginal birth after cesarean (VBAC) clinical management guidelines will be enrolled and recorded by our homemade registration form of TOLAC. In the non-cesarean section group, pregnant women after 37 weeks of gestation after spontaneous labor but without vaginal labor contraindications will be enrolled. After spontaneous labor for 24h, their final delivery mode will be recorded. In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
510
Inclusion Criteria
  1. Volunteers sign the informed consent
  2. Age: 20-40 years;
  3. Singleton, a cephalic presentation;
  4. No contradiction to vaginal delivery; 5.39~42 weeks; 6.Spontaneous labor

Exclusion criteria:

  1. Konwn contraindication to vaginal delivery or severe complications;
  2. Multiple gestation;
  3. Uterine malformation;
  4. Severe psychiatric disorder;
  5. Without family's support.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vignial birth rate24 hours

After spontaneous labor for up tp 24h, the mode of delivery will be konwn and recorded.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

First Affiliated Hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China
Tang Jinhai
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.